News
For Sarepta, the hits keep coming, with several downgrades in the past week after it was forced to temporarily take its ...
Arrowhead Pharmaceuticals has moved to reassure Wall Street about its deal with Sarepta Therapeutics, telling investors that ...
Sarepta Therapeutics' licensing partner Arrowhead Pharmaceuticals said on Wednesday it expects to receive near-term milestone ...
BioMarin downgraded to Hold amid rising competition, pipeline concerns, and ambitious growth targets, despite solid Q1 2025 ...
10hon MSN
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. A visit to the chiropractor can provide many health benefits.
Roche Holding AG paused some shipments of the controversial gene therapy Elevidys following a similar action by the embattled ...
Analysts downgraded Sarepta as FDA pause on Elevidys raises regulatory uncertainty, leading to significant stock pressure and valuation cuts.
A timeline of key developments surrounding Sarepta Therapeutics' Duchenne muscular dystrophy drug Elevidys, and the potential ...
An experimental oral treatment from Abivax helped ease symptoms in patients with ulcerative colitis, a major win for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results